Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
1.680
-0.030 (-1.75%)
At close: Mar 9, 2026, 4:00 PM EDT
1.660
-0.020 (-1.19%)
After-hours: Mar 9, 2026, 5:57 PM EDT

Lexicon Pharmaceuticals Market Cap

Lexicon Pharmaceuticals has a market cap or net worth of $717.50 million as of March 9, 2026. Its market cap has increased by 173.44% in one year.

Market Cap
717.50M
Enterprise Value
679.55M
1-Year Change
173.44%
Ranking
Category
Stock Price
$1.68

Market Cap Chart

Since April 7, 2000, Lexicon Pharmaceuticals's market cap has decreased from $890.90M to $717.50M, a decrease of -19.46%. That is a compound annual growth rate of -0.83%.

History

DateMarket Cap% Change
Mar 6, 2026724.50M73.37%
Dec 31, 2025417.90M56.46%
Dec 31, 2024267.10M-28.72%
Dec 29, 2023374.70M3.94%
Dec 30, 2022360.50M-38.54%
Dec 31, 2021586.60M45.99%
Dec 31, 2020401.80M-8.89%
Dec 31, 2019441.00M-37.30%
Dec 31, 2018703.30M-32.58%
Dec 29, 20171.04B-27.50%
Dec 30, 20161.44B4.32%
Dec 31, 20151.38B194.45%
Dec 31, 2014468.40M-49.30%
Dec 31, 2013923.80M-18.41%
Dec 31, 20121.13B159.94%
Dec 30, 2011435.60M-10.39%
Dec 31, 2010486.10M62.74%
Dec 31, 2009298.70M55.98%
Dec 31, 2008191.50M-53.80%
Dec 31, 2007414.50M50.51%
Dec 29, 2006275.40M16.89%
Dec 30, 2005235.60M-52.10%
Dec 31, 2004491.90M33.02%
Dec 31, 2003369.80M49.35%
Dec 31, 2002247.60M-58.67%
View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
CytomX Therapeutics 792.96M
Kura Oncology 791.43M
Eikon Therapeutics 776.29M
Annexon 769.13M
Bright Minds Biosciences 762.41M
Prime Medicine 710.09M
Gyre Therapeutics 700.76M
ProKidney 691.92M
Market Cap Rankings